(Q39356288)

English

Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine

scientific article published on 19 January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

hemodialysis patient

1 reference

based on heuristic

inferred from title

author name string

Jörg Filitz

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Norbert Griessinger

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Reinhard Sittl

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Rudi Likar

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Jürgen Schüttler

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Wolfgang Koppert

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

19 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

European Journal of Pain

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

743-748

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Removal of morphine but not fentanyl during haemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Mandatory sublingual buprenorphine for postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesics

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Pain in hemodialysis patients: prevalence, cause, severity, and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Opioids in renal failure and dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Analgesia in patients with ESRD: a review of available evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

The Metabolism of Phenolic Opiates by Rat Intestine

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Buprenorphine in end stage renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.12.001

21 January 2018

Identifiers

10.1016/J.EJPAIN.2005.12.001

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39356288&oldid=2165180801"